Understanding the Mechanism of Action of Secukinumab Using Lesional Hidradenitis Suppurativa Skin Organ Culture

    Janin Edelkamp, Arnab Pal, J. Viola-Söhnlein … Marta Bertolini
    Studysummary Secukinumab reduces immune activity in hidradenitis suppurativa skin.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jidonline.org →
    Discuss this study in the Community →